Skin MD by Dr Monika Kiripolsky recalled its Body Acne Cleanser on September 12, 2025. The recall follows the discovery of elevated benzene levels in the product. This contamination poses a high health risk to consumers in California and Georgia.
Chemical Contamination: This recall has been initiated due to elevated levels of benzene that was discovered during post consume awareness with benzoyl peroxide products.
Consumers and healthcare providers should stop using this product immediately. Contact Private Label Skin Care Inc. or your healthcare provider for guidance. Notification method: Letter
The recalled product is Skin MD Body Acne Cleanser, containing 10% benzoyl peroxide, in 7 oz (201 g) bottles. It is associated with Lot # 58170A and 58172A, with an expiration date of September 2025. The product was distributed in California and Georgia.
The recall was initiated due to the detection of elevated levels of benzene, a harmful chemical. Benzene exposure can lead to serious health issues, making this a significant safety concern.
No specific incidents or injuries have been reported related to this recall. However, the presence of benzene poses a high risk to users.
Consumers should stop using the product immediately. Contact Private Label Skin Care Inc. or consult your healthcare provider for further guidance.
For more information, visit the FDA website at https://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?recall_number=D-0664-2025 or reach out to Private Label Skin Care Inc.
Get notified about recalls in categories you care about.
Bristol-Myers Squibb recalled 12,778 vials of Opdualag injection on October 21, 2025. The recall stems from a lack of assurance of sterility. The affected products were distributed nationwide in the United States.
Major Pharmaceuticals recalled Gabapentin Capsules, USP, 100 mg, on October 10, 2025, due to failed impurities specifications. The recall affects several lot numbers distributed nationwide. Consumers must stop using the affected capsules immediately.
Lannett Company, Inc. recalled 46,848 bottles of Niacin Extended-release Tablets on October 10, 2025. The recall follows reports of failed dissolution specifications, which could affect medication effectiveness. Consumers should stop using the product immediately and consult healthcare providers for guidance.